Science Corporation, led by former Neuralink co-founder Max Hodak, is championing a future where traditional screens, keyboards, and physical devices are eventually phased out. The company is heavily investing in brain-computer interface (BCI) technology to create seamless, direct interactions between humans and machines.
The startup has already demonstrated tangible medical breakthroughs, notably its PRIMA implant, which successfully restores sight to individuals suffering from severe vision loss. With significant venture backing and upcoming U.S. human trials led by prominent neurobiologists, Science Corp is expanding its research toward addressing neurological disorders, seizures, and mobility challenges.
Hodak’s vision for a post-screen era highlights a major paradigm shift in technology design. By moving away from flat displays toward adaptive neural interfaces, the next generation of computing aims to integrate directly with human biology rather than requiring external physical peripherals.
- Science Corp is developing neural interfaces to replace traditional screens and keyboards.
- The PRIMA retinal implant has successfully helped restore sight to visually impaired patients.
- The company is preparing for its first U.S. human trials for biohybrid BCI tech.
- Future applications include treating neurological conditions, Parkinson’s, and epilepsy.
Sources:
